| Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis S Rezaei, B Fatemi, Z Karimi Majd, H Minaei, M Peikanpour, N Anjidani, ... Expert review of clinical immunology 17 (5), 499-511, 2021 | 36 | 2021 |
| Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country H Minaei, M Peikanpour, N Yousefi, P Peymani, F Peiravian, N Shobeiri, ... Iranian Journal of Pharmaceutical Research: IJPR 18 (4), 2191, 2019 | 10 | 2019 |
| Cost-Effectiveness Analysis of Macitentan in Comparison With Bosentan in the Treatment of Pulmonary Arterial Hypertension in Iran M Ekhlasi, S Sheikhi, ZK Majd, F Peiravian, N Yousefi Value in Health Regional Issues 34, 78-85, 2023 | 1 | 2023 |
| Use Pattern of Personal Care Products: A Cross-Sectional National Survey ZK Majd, M Peikanpour, SM Ghasemi, S Esmaeili, H Rasekh, R Sadeghi, ... International Pharmacy Acta 5 (1), e12: 1-14, 2021 | | 2021 |
| COST-EFFECTIVENESS ANALYSIS OF PALBOCICLIB PLUS FULVESTRANT VERSUS EVEROLIMUS PLUS EXEMESTAN IN THE TREATMENT OF ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE, ADVANCED BREAST … S Taheri, ZK Majd, S Rezaei, N Yousefi, F Peiravian ISPOR Europe 2019, 2019 | | 2019 |
| COST-UTILITY ANALYSIS OF ABIRATERONE IN THE TREATMENT OF DOCETAXEL-REFRACTORY METASTATIC CASTRATION-RESISTANT PROSTATE CANCER COMPARED TO BEST SUPPORTIVE CARE IN IRAN S Taheri, ZK Majd, N Yousefi, F Peiravian ISPOR Europe 2019, 2019 | | 2019 |
| PUK20 ECONOMIC EVALUATION OF CILOSTAZOL IN COMPARISON WITH PENTOXIFYLLINE IN THE TREATMENT OF INTERMITTENT CLAUDICATION IN IRAN ZK Majd, S Taheri, N Yousefi, F Peiravian Value in Health 22, S916, 2019 | | 2019 |
| PUK16 COST-UTILITY ANALYSIS OF MIRABEGRON VERSUS ANTIMUSCARINIC THERAPY IN THE TREATMENT OF OVERACTIVE BLADDER ZK Majd, S Taheri, N Yousefi, F Peiravian Value in Health 22, S915-S916, 2019 | | 2019 |
| PHP196-DEVELOPMENT STRATEGIES PROMOTING PHARMACEUTICAL INDUSTRY TO IMPROVE HEALTHCARE MANAGEMENT J Babapour, M Peikanpour, ZK Majd, MP Moghaddam, S Sheikhi Value in Health 21, S183, 2018 | | 2018 |
| PMU56-ECONOMIC EVALUATION OF POSACONAZOLE IN COMPARISON WITH LIPOSOMAL AMPHOTERICIN B IN THE TREATMENT OF MUCORMYCOSIS IN IRAN ZK Majd, S Taheri, L Zarei, F Peiravian, N Yousefi Value in Health 21, S317, 2018 | | 2018 |
Nazila YousefiAssociate Professor in Pharmacoeconomics and Pharma Management, School of Pharmacy, SBMU在 sbmu.ac.ir 的电子邮件经过验证
